Novartis receives EC Approval for Beovu, a next-generation anti-VEGF treatment for wet AMD, a leading cause of blindness worldwide Read more
PharmaMar and Jazz Announce FDA Acceptance and Priority Review of New Drug Application for Lurbinectedin in Relapsed Small Cell Lung Cancer Read more
Zydus Cadila launches a fast tracked programme to develop vaccine for the novel coronavirus, 2019-nCoV (COVID-19) Read more
Seattle Genetics gets FDA priority review for tucatinib in locally advanced or metastatic HER2-positive breast cancer Read more
FDA Grants Soligenix “Fast Track” Designation for RiVax in the Prevention of Ricin Poisoning Read more
Vir Biotechnology Identifies Two Antibodies That Bind to the Spike Protein of 2019-nCoV, Newly Named as SARS-CoV-2 Read more